MRC AML12: A comparison of ADE vs MAE and S-DAT vs H-DAT+retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML

AK Burnett; Keith Wheatley; AH Goldstone; B Gibson; D Webb; AG Prentice; Donald Milligan

MRC AML12: A comparison of ADE vs MAE and S-DAT vs H-DAT+retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML

AK Burnett, Keith Wheatley, AH Goldstone, B Gibson, D Webb, AG Prentice, Donald Milligan

Research output: Contribution to conference (unpublished) › Paper

Original language	English
Pages	155a Abs 582
Publication status	Published - 1 Jan 2002

Cite this

@conference{78fe659615004f088501ae08f20a2789,

title = "MRC AML12: A comparison of ADE vs MAE and S-DAT vs H-DAT+retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML",

author = "AK Burnett and Keith Wheatley and AH Goldstone and B Gibson and D Webb and AG Prentice and Donald Milligan",

year = "2002",

month = jan,

day = "1",

language = "English",

pages = "155a Abs 582",

}

TY - CONF

T1 - MRC AML12: A comparison of ADE vs MAE and S-DAT vs H-DAT+retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML

AU - Burnett, AK

AU - Wheatley, Keith

AU - Goldstone, AH

AU - Gibson, B

AU - Webb, D

AU - Prentice, AG

AU - Milligan, Donald

PY - 2002/1/1

Y1 - 2002/1/1

M3 - Paper

SP - 155a Abs 582

ER -